Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02661672 · ClinicalTrials.gov registry record · NA
INVEST-REGISTRY: Minimally Invasive Endoscopic Surgical Treatment With Apollo/Artemis in Patients With Brain Hemorrhage
A NA study of Intracranial Hemorrhage, sponsored by J. Moc.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 7
- Study locations
NCT02661672 is a NA study of Intracranial Hemorrhage that has completed, run by J. Moc. The registered enrollment target is 38 participants. The trial reports 7 study locations across 6 states.
The verdict
NCT02661672, a NA study of Intracranial Hemorrhage, has completed, sponsored by J. Moc.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 7
- Study locations
Study Summary
Objective: The primary objective of this multicenter prospective registry is to provide additional safety, technical outcomes and clinical outcomes data for minimally invasive endoscopic surgery (MIES) with Apollo or Artemis for the evacuation of supratentorial brain hemorrhage in adult patients who do not qualify for the concurrent INVEST Feasibility randomized controlled trial at active INVEST centers.
Conditions Studied
Interventions
- DEVICE Apollo Device
- DEVICE Artemis Device
Study Locations (7)
New York
- University of Buffalo - Buffalo
- Icahn School of Medicine at Mount Sinai - New York
District of Columbia
- George Washington University - Washington D.C.
Kentucky
- University of Louisville - Louisville
Pennsylvania
- Geisinger Medical Center - Danville
South Carolina
- Prisma Health - Greenville
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2016-10-14 |
| Est. Completion | 2022-11-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02661672
The ClinicalTrials.gov registry entry for NCT02661672 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is J. Moc, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intracranial Hemorrhage appearing as the primary indexed condition, and to 2 interventions - of which Apollo Device is the first listed.
NCT02661672 reports 7 study locations spanning 6 distinct geographic areas - top geographies include New York, District of Columbia, Kentucky.
Frequently Asked Questions
What is clinical trial NCT02661672 about?
NCT02661672 is a clinical study titled "INVEST-REGISTRY: Minimally Invasive Endoscopic Surgical Treatment With Apollo/Artemis in Patients With Brain Hemorrhage". Objective: The primary objective of this multicenter prospective registry is to provide additional safety, technical outcomes and clinical outcomes data for minimally invasive endoscopic surgery (MIES) with Apollo or Artemis for the evacuation of supratentorial brain hemorrhage in adult patients who...
What is the current status of trial NCT02661672?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2016-10-14. Estimated completion is 2022-11-16.
What conditions does trial NCT02661672 study?
This clinical trial studies the following conditions: Intracranial Hemorrhage.
What interventions are being tested in trial NCT02661672?
The interventions under investigation include: Apollo Device (DEVICE), Artemis Device (DEVICE).
Who is sponsoring clinical trial NCT02661672?
This trial is sponsored by J. Moc, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02661672 being conducted?
This trial has 7 study locations across District of Columbia, Kentucky, New York, Pennsylvania, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.